The Nanomedicine Lab 2.0 Mission is to generate and disseminate fundamental knowledge in the field of nanomedicine by convergence of nanotechnology, bioengineering, pharmacology, neuroscience, cell biology, omics and their translation to advanced, clinically relevant and safe therapeutics and diagnostics
MORE ABOUT USRESEARCH TEAMS
The NanoOmics Team aims to harness the interactions of nanomaterials with blood components
The NanoInflammation Team studies how nanomaterials may cause inflammation or be used to modulate inflammation and control disease
The NanoCell Biology Team unveils interactions of nanomaterials with living cells and their structural compartments
The NanoNeuro Team studies the use of graphene-based neural interface technologies in the neurophysiology of brain disorders
The NanoTherapeutics Team exploits the unique properties of nanoparticles to develop clinically translatable advanced medicines
The Nanomedicine@ICN2 Team designs, fabricates and characterizes advanced nanomaterials at biological grade for medical use
